BCR and neoplasm: A recent study [17] analyzed TCR and B cell receptor (BCR) repertoires in sorted cell subsets of tumor, distant non-tumor tissue (NT), and peripheral compartments (blood/draining lymph node) from 47 non-small cell lung cancer (NSCLC) patients and identified distinct adaptive immune responses in NSCLC.